Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,980,227
-$33,343 QoQ
Shares Held
1,667,119
0.0% QoQ
Ownership
2.55%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#5
of 78 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EcoR1 Capital, LLC holds $1,935,887,028 across 29 Biotechnology names. LKFT ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
|
22,970,388 | $600,445,942 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $531,906,345 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $155,492,635 | |
| 4 | CGON |
CG Oncology, Inc.
|
1,494,300 | $106,170,015 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
1,389,276 | $75,771,113 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $72,865,496 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
3,174,519 | $63,871,322 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
This page
|
1,667,119 | $49,980,227 |
All Filings in LKFT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,980,227 | 1,667,119 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,013,570 | 1,667,119 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,514,791 | 1,667,119 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $57,749,002 | 1,667,119 | Shares | Sole | 2025-11-14 | |
| 2025-07-24 | $268,843,003 | 8,714,522 | Shares | Sole | 2025-07-28 | |
| 2025-06-30 | $29,024,090 | 1,036,945 | Shares | Sole | 2025-08-14 | |
| 2025-05-15 | $209,594,005 | 7,803,202 | Shares | Sole | 2025-05-19 | |
| 2025-03-31 | $3,893,750 | 155,006 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,262,665 | 155,006 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,462,622 | 155,006 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $142,640,321 | 5,756,268 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $185,351,829 | 5,756,268 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $233,992,294 | 5,756,268 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $198,879,059 | 5,756,268 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $234,049,856 | 5,756,268 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $164,013,082 | 4,244,645 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $165,569,797 | 3,730,730 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $136,341,400 | 3,197,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $178,420,500 | 3,197,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $198,192,600 | 3,195,624 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $122,631,337 | 2,224,403 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,005,784 | 1,558,749 | Shares | Sole | 2021-11-22 | |
| 2020-12-31 | $4,619,000 | 46,666 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||